Liver cancer

• For Researchers

Field notes from a hepatologist

Dr Matt Hoare explores the cancerisation field effect in liver disease and thinks cancer researchers need to pay attention to the increasing incidence of metabolic disorders… Dr Matt Hoare explores the cancerisation field effect in liver disease and thinks cancer researchers need to pay attention to the increasing incidence of metabolic disorders…

3 October 2023

• Health & Medicine

Liver cancer rates in the UK are highest amongst men in Scotland

A new study has has revealed the variation in the number of people being diagnosed with liver cancer across the UK. A new study has has revealed the variation in the number of people being diagnosed with liver cancer across the UK.

9 April 2021

• Science & Technology

Gentle regular exercise could reduce the risk of liver cancer in mice

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

15 February 2021

• Health & Medicine

Liver cancer deaths climb by around 50% in the last decade

Liver cancer deaths have increased by around 50% in the last decade and have tripled since records began Liver cancer deaths have increased by around 50% in the last decade and have tripled since records began

1 November 2019

• Health & Medicine

Obese people outnumber smokers two to one

People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types. People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types.

3 July 2019

• Health & Medicine

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer. Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

17 April 2019

• Health & Medicine

Clinical trial launches to develop breath test for multiple cancers

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.

2 January 2019

• Health & Medicine

Targeted cancer drug made available for some NHS liver cancer patients

A targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS. A targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.

29 November 2018

• Health & Medicine

Liver cancer: UK’s fastest rising cause of cancer death to be tackled

A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK. A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK.

20 September 2018

• Health & Medicine

Drug could protect children from hearing loss after chemo

New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin.

20 June 2018

• Science & Technology

Cancer blood tests and learning from HIV – our latest Pioneer Awards

Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets. Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.

29 September 2017

• Health & Medicine

3 in 4 Cancer Drugs Fund treatments now available on NHS

Three quarters of the drugs previously only accessible to patients via the Cancer Drugs Fund (CDF) are now approved on the NHS. Three quarters of the drugs previously only accessible to patients via the Cancer Drugs Fund (CDF) are now approved on the NHS.

11 August 2017